Cambridge Core: Examining Access to Care in Clinical Genomic Research and Medicine: Experiences from the CSER Consortium (Tomlinson)
Evidence-Generating Research consortium (CSER) presents opportunities to examine access to
genomic medicine across diverse contexts. CSER emphasizes engaging historically
underrepresented and/or underserved populations. We used descriptive analysis of CSER
participant survey data and qualitative case studies to explore anticipated and encountered access
barriers and interventions to address them.
with many Spanish-preferring individuals. In surveys, less than a fifth (18.6%) of participants
reported experiencing barriers to care. However, CSER project case studies revealed a more
nuanced picture that highlighted the blurred boundary between access to genomic research and
clinical care. Drawing on insights from CSER, we build on an existing framework to characterize
the concept and dimensions of access to genomic medicine along with associated measures and
encompassing multiple dimensions, using mixed methods to study access issues, and investing in
innovative improvement strategies. This conceptualization may inform clinical translation of
other cutting-edge technologies and contribute to the promotion of equitable, effective, and
efficient access to genomic medicine.
precision medicine, access to care, access to genomic medicine, health policy, health equity,
Since 2004, UT Health San Antonio, Greehey Children’s Cancer Research Institute’s (Greehey CCRI) mission has been to advance scientific knowledge relevant to childhood cancer, contribute to the understanding of its causes, and accelerate the translation of knowledge into novel therapies. Through discovery, development, and dissemination of new scientific knowledge, Greehey CCRI strives to have a national and global impact on childhood cancer. Our mission consists of three key areas — research, clinical, and education.